早期类风湿关节炎的生物治疗

Bio-therapy for Early Rheumatoid Arthritis

随着类风湿性关节炎研究的深入,生物制剂治疗类风湿性关节炎是一种趋势.针对不同靶点如T细胞、B细胞、细胞因子和黏附分子及其受体等的生物制剂研究并应用于临床.这些生物制剂克服了以往传统药物的缺点,而显示出其独特的优势,生物制剂将成为以后临床重要的一类治疗药物.

With the further study of rheumatoid arthritis,biological agents has become a trend in the treatment of rheumatoid arthritis.Biological agents acting on different targets such as T lymphocyte,B lymphocyte,cytokine,adhesion molecule as well as their receptors are being explored and being applied in clinic,which shows their own advantages by overcoming shortcomings of traditional drugs.So biological agents will be a kind of important drugs in clinic in future.